Novel TBK1 truncating mutation in a familial amyotrophic lateral sclerosis patient of Chinese origin
暂无分享,去创建一个
M. Marshall | E. Duncan | D. Rowe | K. Williams | I. Blair | G. Nicholson | Katharine Y. Zhang | P. Leo | E. McCann | J. Fifita
[1] Brittany N. Lasseigne,et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways , 2015, Science.
[2] T. Wieland,et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia , 2015, Nature Neuroscience.
[3] J. Trojanowski,et al. Variants associated with Gaucher disease in multiple system atrophy , 2015, Annals of clinical and translational neurology.
[4] G. Nicholson,et al. Analysis of dynein intermediate chains, light intermediate chains and light chains in a cohort of hereditary peripheral neuropathies , 2014, neurogenetics.
[5] S. Myers,et al. Mutations in the SPTLC1 protein cause mitochondrial structural abnormalities and endoplasmic reticulum stress in lymphoblasts. , 2014, DNA and cell biology.
[6] I. Blair,et al. Mutant Human FUS Is Ubiquitously Mislocalized and Generates Persistent Stress Granules in Primary Cultured Transgenic Zebrafish Cells , 2014, PloS one.
[7] Jana Marie Schwarz,et al. MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.
[8] Adriano Chiò,et al. State of play in amyotrophic lateral sclerosis genetics , 2013, Nature Neuroscience.
[9] Robert H. Brown,et al. ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19. , 2013, American journal of human genetics.
[10] Olubunmi Abel,et al. Development of a Smartphone App for a Genetics Website: The Amyotrophic Lateral Sclerosis Online Genetics Database (ALSoD) , 2013, JMIR mHealth and uHealth.
[11] K. Williams,et al. Mutation analysis and immunopathological studies of PFN1 in familial and sporadic amyotrophic lateral sclerosis , 2013, Neurobiology of Aging.
[12] K. Mathews,et al. Re‐analysis of an original CMTX3 family using exome sequencing identifies a known BSCL2 mutation , 2013, Muscle & nerve.
[13] G. Crabtree,et al. Exome sequencing to identify de novo mutations in sporadic ALS trios , 2013, Nature Neuroscience.
[14] S. Züchner,et al. A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene. , 2013, Human molecular genetics.
[15] T. Maniatis,et al. Crystal structure and mechanism of activation of TANK-binding kinase 1. , 2013, Cell reports.
[16] W. Hahn,et al. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. , 2013, Cell reports.
[17] M. Swash,et al. Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.
[18] J. Lupski,et al. A Loss‐of‐Function Variant in the Human Histidyl‐tRNA Synthetase (HARS) Gene is Neurotoxic In Vivo , 2013, Human mutation.
[19] Joaquín Dopazo,et al. Qualimap: evaluating next-generation sequencing alignment data , 2012, Bioinform..
[20] M. Ryan,et al. A family with 2 X‐linked disorders: Charcot‐Marie‐Tooth disease and hemophilia A , 2012, Muscle & nerve.
[21] Leonard H van den Berg,et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. , 2012, Human molecular genetics.
[22] N. Luquin,et al. A novel TARDBP insertion/deletion mutation in the flail arm variant of amyotrophic lateral sclerosis , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[23] S. Tsuji,et al. The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. , 2012, American journal of human genetics.
[24] S. Tsuji,et al. Mutational origin of Machado-Joseph disease in the Australian Aboriginal communities of Groote Eylandt and Yirrkala. , 2012, Archives of neurology.
[25] Mark Latt,et al. “Dancing feet dyskinesias”: A clue to parkin gene mutations , 2012, Movement disorders : official journal of the Movement Disorder Society.
[26] H. Hakonarson,et al. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. , 2012, Human molecular genetics.
[27] Kelly L. Williams,et al. Mutation analysis of the optineurin gene in familial amyotrophic lateral sclerosis , 2012, Neurobiology of Aging.
[28] R. Ritch,et al. Confirmation of TBK1 duplication in normal tension glaucoma. , 2012, Experimental eye research.
[29] I. Blair,et al. Molecular genetics and mechanisms of disease in distal hereditary motor neuropathies: insights directing future genetic studies. , 2011, Current molecular medicine.
[30] G. Superti-Furga,et al. Functional Dissection of the TBK1 Molecular Network , 2011, PloS one.
[31] A. Mes-Masson,et al. KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. , 2011, American journal of human genetics.
[32] M. Ryan,et al. A retrospective review of X-linked Charcot-Marie-Tooth disease in childhood , 2011, Neurology.
[33] Liang Xu,et al. [Is normal-tension glaucoma different from primary open-angle glaucoma]. , 2011, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.
[34] Nancy F. Hansen,et al. Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. , 2010, American journal of human genetics.
[35] I. Blair,et al. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases. , 2010, The international journal of biochemistry & cell biology.
[36] I. Blair,et al. Fused in sarcoma/translocated in liposarcoma: a multifunctional DNA/RNA binding protein. , 2010, The international journal of biochemistry & cell biology.
[37] G. Nicholson,et al. Correlation between muscle atrophy on MRI and manual strength testing in hereditary neuropathies , 2010, Journal of Clinical Neuroscience.
[38] Takeo Kato,et al. Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.
[39] K. Flanigan,et al. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy , 2010, Neuromuscular Disorders.
[40] T. Ferguson,et al. Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. , 2010, American journal of human genetics.
[41] G. Nicholson,et al. X-linked CMT: genes and gene loci in an Australian cohort , 2010, neurogenetics.
[42] T. Hornemann,et al. Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids*♦ , 2010, The Journal of Biological Chemistry.
[43] M. Kiernan,et al. Cortical excitability in hereditary motor neuronopathy with pyramidal signs: comparison with ALS , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[44] M. Kiernan,et al. FUS mutations in amyotrophic lateral sclerosis: clinical, pathological, neurophysiological and genetic analysis , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[45] K. Williams,et al. A novel TARDBP mutation in an Australian amyotrophic lateral sclerosis kindred , 2009, Journal of Neurology, Neurosurgery & Psychiatry.
[46] S. Züchner,et al. Phenotypic spectrum of dynamin 2 mutations in Charcot-Marie-Tooth neuropathy. , 2009, Brain : a journal of neurology.
[47] Xun Hu,et al. Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.
[48] T. Hornemann,et al. A systematic comparison of all mutations in hereditary sensory neuropathy type I (HSAN I) reveals that the G387A mutation is not disease associated , 2009, neurogenetics.
[49] H. Shill,et al. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study , 2008, BMC medicine.
[50] J. Pollard,et al. Histopathological Findings in Hereditary Motor and Sensory Neuropathy of Axonal Type With Onset in Early Childhood Associated With Mitofusin 2 Mutations , 2008, Journal of neuropathology and experimental neurology.
[51] S. Leal,et al. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. , 2008, American journal of human genetics.
[52] P. Schofield,et al. Pedigree with frontotemporal lobar degeneration – motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9 , 2008, BMC neurology.
[53] T. Gillis,et al. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: The GenePD study , 2008, Movement disorders : official journal of the Movement Disorder Society.
[54] H. Shill,et al. Haplotypes and gene expression implicate the MAPT region for Parkinson disease , 2008, Neurology.
[55] A. Antonellis,et al. Evidence of a founder haplotype refines the X-linked Charcot–Marie-Tooth (CMTX3) locus to a 2.5 Mb region , 2008, neurogenetics.
[56] M. Ryan,et al. Autosomal dominant congenital spinal muscular atrophy – A possible developmental deficiency of motor neurones? , 2008, Neuromuscular Disorders.
[57] Christine Klein,et al. Replication of association between ELAVL4 and Parkinson disease: the GenePD study , 2008, Human Genetics.
[58] M. Kiernan,et al. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. , 2008, Brain : a journal of neurology.
[59] J. Vallat,et al. Severe early-onset axonal neuropathy with homozygous and compound heterozygous MFN2 mutations , 2008, Neurology.
[60] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[61] S. Tsuji,et al. Asian origin for the worldwide-spread mutational event in Machado-Joseph disease. , 2007, Archives of neurology.
[62] M. Shy,et al. Stoichiometric alteration of PMP22 protein determines the phenotype of hereditary neuropathy with liability to pressure palsies. , 2007, Archives of neurology.
[63] K. Claeys,et al. Hereditary spastic paraplegia 3A associated with axonal neuropathy. , 2007, Archives of neurology.
[64] M. Ryan,et al. Establishment of the Australasian paediatric Charcot-Marie-Tooth disease registry , 2007, Neuromuscular Disorders.
[65] I. Blair,et al. A novel locus for distal motor neuron degeneration maps to chromosome 7q34-q36 , 2007, Human Genetics.
[66] M. MacDonald,et al. Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age , 2006, Neurology.
[67] G. Nicholson,et al. Proof of genetic heterogeneity in X-linked Charcot–Marie–Tooth disease , 2006, Neurology.
[68] S. Love,et al. Late-onset hereditary sensory neuropathy type I due to SPTLC1 mutation: Autopsy findings , 2006, Clinical Neurology and Neurosurgery.
[69] S. Züchner,et al. G.O. 9 Dynamin 2 mutations are associated with dominant intermediate Charcot-Marie-Tooth disease and dominant centronuclear myopathy , 2006, Neuromuscular Disorders.
[70] T. Gillis,et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. , 2006, Archives of neurology.
[71] G. Nicholson. The dominantly inherited motor and sensory neuropathies: Clinical and molecular advances , 2006, Muscle & nerve.
[72] S. Myers,et al. Intermediate forms of Charcot-Marie-Tooth neuropathy: a review. , 2006, Neuromolecular medicine.
[73] H. Shill,et al. BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study , 2005, Neurology.
[74] J. Pollard,et al. Autosomal dominant hereditary sensory neuropathy with chronic cough and gastro-oesophageal reflux: clinical features in two families linked to chromosome 3p22-p24. , 2005, Brain : a journal of neurology.
[75] K. Fischbeck,et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. , 2005, Brain : a journal of neurology.
[76] A. Kochański,et al. Mild early onset axonal Charcot-Marie-Tooth disease not linked to other axonal Charcot-Marie-Tooth loci , 2005, Neurology.
[77] Danqing Zhu,et al. Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease , 2005, Nature Genetics.
[78] G. Nicholson,et al. AGE DEPENDENT PENETRANCE OF THREE DIFFERENT SUPEROXIDE DISMUTASE 1 (SOD 1) MUTATIONS , 2005, The International journal of neuroscience.
[79] I. Dedova,et al. Hypoxia Causes Aggregation of Serine Palmitoyltransferase followed by Non-Apoptotic Death of Human Lymphocytes , 2004, Cell cycle.
[80] S. Myers,et al. Transcript map of the candidate region for HSNI with cough and gastroesophageal reflux on chromosome 3p and exclusion of candidate genes , 2004, Neurogenetics.
[81] John W Griffin,et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). , 2004, American journal of human genetics.
[82] I. Dedova,et al. Activity of partially inhibited serine palmitoyltransferase is sufficient for normal sphingolipid metabolism and viability of HSN1 patient cells. , 2004, Biochimica et biophysica acta.
[83] Erdahl T. Teber,et al. Tau haplotypes regulate transcription and are associated with Parkinson's disease , 2004, Annals of neurology.
[84] I. Dedova,et al. Equilibrium Between Cell Division and Apoptosis in Immortal Cells as an Alternative to the G1 Restriction Mechanism in Mammalian Cells , 2004, Cell cycle.
[85] J. Pollard,et al. A locus for hereditary sensory neuropathy with cough and gastroesophageal reflux on chromosome 3p22-p24. , 2003, American journal of human genetics.
[86] I. Dedova,et al. Inhibition of topoisomerase II overrides the G2/M check points of the cell cycle in EBV-lymphocytes , 2003, Apoptosis.
[87] Hanns Lochmüller,et al. Mutation screening of the N‐myc downstream‐regulated gene 1 (NDRG1) in patients with Charcot‐Marie‐Tooth Disease , 2003, Human mutation.
[88] J. Pollard,et al. Peripheral neuropathies of infancy. , 2003, Developmental medicine and child neurology.
[89] M. Verheijen,et al. Refined localization of dominant intermediate Charcot-Marie-Tooth neuropathy and exclusion of seven known candidate genes in the region , 2003, Neurogenetics.
[90] H. Hartung,et al. Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: a review. , 2003, Archives of neurology.
[91] S. Vucic,et al. CMT with pyramidal features , 2003, Neurology.
[92] S. Brahmbhatt,et al. Exclusion of serine palmitoyltransferase long chain base subunit 2 (SPTLC2) as a common cause for hereditary sensory neuropathy , 2002, Neuromuscular Disorders.
[93] G. Nicholson,et al. Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation , 2002, Journal of neurology, neurosurgery, and psychiatry.
[94] H. Hartung,et al. Autosomal dominant juvenile amyotrophic lateral sclerosis and distal hereditary motor neuronopathy with pyramidal tract signs: synonyms for the same disorder? , 2002, Brain : a journal of neurology.
[95] G. Nicholson,et al. Friedreich's ataxia with chorea and myoclonus caused by a compound heterozygosity for a novel deletion and the trinucleotide GAA expansion , 2002, Movement disorders : official journal of the Movement Disorder Society.
[96] R. Ritch,et al. Adult-Onset Primary Open-Angle Glaucoma Caused by Mutations in Optineurin , 2002, Science.
[97] E. Storey,et al. A new autosomal dominant pure cerebellar ataxia , 2001, Neurology.
[98] S. Robertson,et al. Dominant intermediate Charcot-Marie-Tooth neuropathy maps to chromosome 19p12-p13.2. , 2001, American journal of human genetics.
[99] S. Brahmbhatt,et al. Hereditary sensory neuropathy type I: haplotype analysis shows founders in southern England and Europe. , 2001, American journal of human genetics.
[100] S. Brahmbhatt,et al. Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I , 2001, Nature Genetics.
[101] C. Masters,et al. Variable phenotype of Alzheimer's disease with spastic paraparesis , 2001, Journal of neurochemistry.
[102] J. Pollard,et al. Clinical syndromes associated with tomacula or myelin swellings in sural nerve biopsies , 2000, Journal of neurology, neurosurgery, and psychiatry.
[103] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[104] M. Bissell. Development of a Multiplex Ligation-Dependent Probe Amplification Assay for Diagnosis and Estimation of the Frequency of Spinocerebellar Ataxia Type 15 , 2010 .
[105] S. Henikoff,et al. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.
[106] K. Refshauge,et al. Night splinting does not increase ankle range of motion in people with Charcot-Marie-Tooth disease: a randomised, cross-over trial. , 2006, The Australian journal of physiotherapy.
[107] M. Ryan,et al. Dominant congenital non progressive motor neuron disorder , 2006 .
[108] G. Nicholson,et al. A rapid and definitive test for Charcot-Marie-Tooth 1A and hereditary neuropathy with liability to pressure palsies using multiplexed real-time PCR. , 2003, Genetic testing.
[109] G. Halliday,et al. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. , 2001, Annals of neurology.